VTI.AU · Visioneering Technologies, Inc

-

Please sign in to comment on VTI.AU

1 Comment

Admin

4 years ago

Visioneering Technologies, Inc is currently in a long term uptrend where the price is trading 490.9% above its 200 day moving average.

From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.

Visioneering Technologies, Inc's total revenue sank by 9.9% to $3M since the same quarter in the previous year.

Its net income has increased by 31.1% to $-4M since the same quarter in the previous year.

Finally, its free cash flow grew by 67.7% to $-968K since the same quarter in the previous year.

Based on the above factors, Visioneering Technologies, Inc gets an overall score of 4/5.

CurrencyCode	AUD
ISIN	AU000000VTI2
Exchange	AU
Sector	Healthcare
Industry	Medical Devices

PE Ratio	None
Target Price	0.66
Beta	1.87
Market Cap	4M
Dividend Yield	None

ABOUT

Visioneering Technologies, Inc

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal 1-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

VTI.AU · Visioneering Technologies, Inc

-

Visioneering Technologies, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Visioneering Technologies, Inc using a moving average strategy